EU approves the use of Remdesivir to treat corona virus.
The European Union has authorized the use of a newly revealed vaccine named Remdesivir that can treat severe cases of corona virus.
The European commission announced it on their twitter handle confirming the speculations and doubt by some citizens.
According to the tweets;
"We have authorized the first medicine Redemsivir to treat #coronavirus at EU level.
"The conditional marketing authorisation comes less than a month after the application was submitted supported by @EMA_News and EU countries.
We have authorised the first medicine, Remdesivir, to treat #coronavirus at EU level.
— European Commission 🇪🇺 (@EU_Commission) July 3, 2020
This conditional marketing authorisation comes less than a month after the application was submitted, supported by @EMA_News and EU countries.
More: https://t.co/PW7P76VzXN #StrongerTogether pic.twitter.com/U3LvRpkUpp
Remdesivir has so far been the only drug that the European Union has authorized for their people to use, as the statement says that the vaccine is for use at the "EU level".
Remdesivir has been shown to speed up the recovery of the corona virus patients and is the only drug that the European countries have authorized, Although the EU has not yet given their opinions on the covid-19 vaccine that was created in Africa in Madagascar.
The authorisation of the drug came after the European Medicine Agency(EMA) encouraged the drug to be used for patients who are suffering pneumonia.
The Remdesivir drug is manufactured by a US drug maker calked Gilead Science.
The announcement was given on July 3rd, the European commissioner, Stella Kyriakides said in a statement;
"Today's authorisation of a first medicine to treat covid19 is an important step forward in the fight against the virus.We are granting the authorisation in less than a month after the application was submitted showing clearly the EU's determination to respond quickly whenever new treatment become available".
Visit our homepage www.gbestvibez.com For News, Updates, Tips and More.StayTuned....
Comments
Post a Comment